Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1693
This examiner grants 36% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18011832 | ANTIVIRAL COMPOUNDS AND METHODS OF USING THE SAME | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17930412 | METHOD FOR IMMOBILIZING NUCLEIC ACID COMPOUND, REAGENT KIT, AND SENSOR | Final Rejection | KABUSHIKI KAISHA TOSHIBA |
| 17995798 | METHODS OF TREATING DIABETIC KIDNEY DISEASE | Final Rejection | AbbVie Inc. |
| 18494749 | METHOD FOR MANUFACTURING CELLULOSE DERIVATIVE | Non-Final OA | SEIKO EPSON CORPORATION |
| 18276397 | SMALL MOLECULE INHIBITORS OF CD38 AS IMMUNOSUPPRESSANTS | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 17619882 | IMPROVED IN VITRO TRANSCRIPTION PURIFICATION PLATFORM | Non-Final OA | ARCTURUS THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy